14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.724 $1.34 Wednesday, 24th Apr 2024 DRRX stock ended at $0.88. This is 4.75% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 11.40% from a day low at $0.82 to a day high of $0.91.
90 days $0.680 $1.44
52 weeks $0.470 $7.46

Historical Durect Corporation prices

Date Open High Low Close Volume
Nov 29, 2023 $0.622 $0.650 $0.611 $0.650 565 023
Nov 28, 2023 $0.645 $0.656 $0.613 $0.623 438 624
Nov 27, 2023 $0.643 $0.659 $0.620 $0.659 380 154
Nov 24, 2023 $0.627 $0.660 $0.627 $0.660 208 024
Nov 22, 2023 $0.630 $0.650 $0.587 $0.650 502 372
Nov 21, 2023 $0.645 $0.645 $0.610 $0.631 239 467
Nov 20, 2023 $0.600 $0.649 $0.600 $0.648 958 708
Nov 17, 2023 $0.598 $0.624 $0.589 $0.613 979 178
Nov 16, 2023 $0.620 $0.620 $0.568 $0.610 533 396
Nov 15, 2023 $0.532 $0.620 $0.531 $0.610 2 140 563
Nov 14, 2023 $0.521 $0.544 $0.510 $0.544 1 134 267
Nov 13, 2023 $0.520 $0.526 $0.481 $0.526 1 219 999
Nov 10, 2023 $0.550 $0.563 $0.470 $0.530 2 204 779
Nov 09, 2023 $0.550 $0.571 $0.530 $0.571 3 348 364
Nov 08, 2023 $0.81 $0.85 $0.511 $0.527 15 395 830
Nov 07, 2023 $2.61 $2.73 $2.54 $2.58 305 830
Nov 06, 2023 $2.73 $2.77 $2.57 $2.59 279 375
Nov 03, 2023 $2.70 $2.89 $2.70 $2.73 268 278
Nov 02, 2023 $3.12 $3.14 $2.60 $2.69 574 466
Nov 01, 2023 $2.75 $3.03 $2.72 $2.98 353 557
Oct 31, 2023 $2.52 $2.79 $2.50 $2.75 356 194
Oct 30, 2023 $2.28 $2.53 $2.28 $2.49 321 920
Oct 27, 2023 $2.36 $2.38 $2.23 $2.24 237 875
Oct 26, 2023 $2.34 $2.37 $2.29 $2.34 199 982
Oct 25, 2023 $2.46 $2.48 $2.34 $2.37 243 890
Click to get the best stock tips daily for free!

About Durect Corporation

Durect DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in... DRRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT